Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Cuban embassy attacked
Accused of ‘fraud’
'He'll do it again'
Not her biological father
Terry Kirkman dies
'I'm at a loss for words'
Dead woman in gator's jaws
Loren undergoes surgery
Pleads guilty to drunk driving
Four-day school schedule
Calif. beach shut down
Can detect human emotions?
To invest $4B in Anthropic
$1.4B for fixes, upgrades
Stroud makes history
S. Korea, US hold joint drills
Thai visa waiver program
Fastest 25K passing yards
Accuses NBC of treason
UK killer nurse to be re-tried
Evaluated for concussion
Sued for losing rare coins?
Better protection for officers
Autoworkers OK labor deal
Quincy shooting arrest
What is a govt. shutdown?
Menendez refuses to resign
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
226,000 results
1h
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
The Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease. The deadly ...
10m
FDA skeptical of experimental ALS treatment pushed by patient advocates
ALS gradually destroys nerve connections needed for basic movements and functions, including breathing. Most people die ...
朝日新聞社29d
FDA approves much-debated Alzheimer’s drug panned by experts
FDA approves much-debated Alzheimer’s drug panned by experts THE ASSOCIATED PRESS June 8, 2021 at 09:15 JST Share Tweet list Print In this 2019 photo provided by Biogen, a researcher works on ...
朝日新聞社10d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
The Courier-Journal5d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
Afro13d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
Salon11d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
Daily Trojan13d
The USC researchers behind a newly approved treatment for Alzheimer’s
USC researchers played a key role in a new treatment for Alzheimer’s disease, the first with full approval to target a suspected root cause of the condition, offering hope to those with the disease ...
Scientific American5d
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet. Josh Fischman: We bring you the latest vital health news: Discoveries that affect ...
Washington Monthly
13d
As Dementia Cases Soar, Who Will Care for the Caregivers?
A CMS pilot project will test a low-cost way to help families support a suffering loved one. It’s more promising than ...
BioPharma Dive
13d
New startup Arialys takes aim at the immune system, hoping to create neuropsychiatry drugs
Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.
Scientific American5d
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet. Josh Fischman: We bring you the latest vital health news: Discoveries that affect ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices